These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 4594340

  • 1. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW, Anderson B, Wigzell H, Fenyö EM, Klein E.
    Int J Cancer; 1974 Jan 15; 13(1):91-104. PubMed ID: 4594340
    [No Abstract] [Full Text] [Related]

  • 2. Antitumour activity in vitro dependent on immune B lymphocytes.
    Lamon EW, Wigzell H, Andersson B, Klein E.
    Nat New Biol; 1973 Aug 15; 244(137):209-11. PubMed ID: 4542206
    [No Abstract] [Full Text] [Related]

  • 3. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC, Gomard E, Levy JP.
    Int J Cancer; 1972 Nov 15; 10(3):589-601. PubMed ID: 4128690
    [No Abstract] [Full Text] [Related]

  • 4. The lymphocyte response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW, Skurzak HM, Klein E.
    Int J Cancer; 1972 Nov 15; 10(3):581-8. PubMed ID: 4128689
    [No Abstract] [Full Text] [Related]

  • 5. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH, Herberman RB, Nunn M, Soares N.
    J Natl Cancer Inst; 1973 Nov 15; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract] [Full Text] [Related]

  • 6. Antibody-dependent lymphocyte cytotoxicity in the murine sarcoma virus system: activity of IgM and IgG with specificity for MLV determined antigen(s).
    Lamon EW, Skurzak HM, Andersson B, Whitten HD, Klein E.
    J Immunol; 1975 Apr 15; 114(4):1171-6. PubMed ID: 1117138
    [Abstract] [Full Text] [Related]

  • 7. The humoral antibody response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW, Klein E, Andersson B, Fenyö EM, Skurzak HM.
    Int J Cancer; 1973 Nov 15; 12(3):637-45. PubMed ID: 4364795
    [No Abstract] [Full Text] [Related]

  • 8. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
    Tamerius JD, Hellström I.
    J Immunol; 1974 Jun 15; 112(6):1987-96. PubMed ID: 4825783
    [No Abstract] [Full Text] [Related]

  • 9. Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.
    Herberman RB, Nunn ME, Lavrin DH, Asofsky R.
    J Natl Cancer Inst; 1973 Nov 15; 51(5):1509-12. PubMed ID: 4543478
    [No Abstract] [Full Text] [Related]

  • 10. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH, McKhann CF, Johnson K, Nelson S.
    Int J Cancer; 1974 Sep 15; 14(3):417-26. PubMed ID: 4459274
    [No Abstract] [Full Text] [Related]

  • 11. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A, Gomard E, Plata F, Levy JP.
    Int J Cancer; 1973 Jul 15; 12(1):233-41. PubMed ID: 4133585
    [No Abstract] [Full Text] [Related]

  • 12. In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumor cell surface antigen.
    Lamon EW, Skurzak HM, Klein E, Wigzell H.
    J Exp Med; 1972 Nov 01; 136(5):1072-9. PubMed ID: 4117188
    [No Abstract] [Full Text] [Related]

  • 13. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F, Levy JP.
    Nature; 1974 May 17; 249(454):271-4. PubMed ID: 4545403
    [No Abstract] [Full Text] [Related]

  • 14. The lymphocyte response to primary Moloney sarcoma virus tumors in BALB-c mice. Definition of the active subpopulations at different times after infection.
    Lamon EW, Wigzel H, Klein E, Andersson B, Skurzak HM.
    J Exp Med; 1973 Jun 01; 137(6):1472-93. PubMed ID: 4709269
    [Abstract] [Full Text] [Related]

  • 15. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW, Whitten HD, Skurzak HM, Andersson B, Lidin B.
    J Immunol; 1975 Nov 01; 115(5):1288-94. PubMed ID: 1080777
    [Abstract] [Full Text] [Related]

  • 16. Decrease of cytotoxic immune lymphoid cells following regression of virus-induced sarcomas in mice.
    Levy JP, Lechlerc JC, Gomard E, Pavie J, Kourilsky F.
    Bibl Haematol; 1973 Nov 01; 39():689-97. PubMed ID: 4798253
    [No Abstract] [Full Text] [Related]

  • 17. Immunologic tolerance to antigens associated with murine leukemia viruses: T-cell unresponsiveness?
    Chieco-Bianchi L, Sendo F, Aoki T, Barrera OL.
    J Natl Cancer Inst; 1974 Apr 01; 52(4):1345-50. PubMed ID: 4133203
    [No Abstract] [Full Text] [Related]

  • 18. Antibody production and interaction with lymphoid cells in relation to tumor immunity in the Moloney sarcoma virus system.
    Harada M, Pearson G, Redmon L, Winters E, Kasuga S.
    J Immunol; 1975 Apr 01; 114(4):1318-22. PubMed ID: 1090675
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.
    Harada M, Pearson G, Pettigrew H, Redmon L, Orr T.
    Cancer Res; 1973 Nov 01; 33(11):2886-93. PubMed ID: 4583975
    [No Abstract] [Full Text] [Related]

  • 20. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.
    Lamon EW.
    J Natl Cancer Inst; 1977 Sep 01; 59(3):769-74. PubMed ID: 70536
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.